Home » Topics » Regulatory

Regulatory
RSS

European Commission approves Cabometyx for HCC previously treated with sorafenib

Nov. 15, 2018

FDA approves Yupelri for maintenance treatment of COPD

Nov. 12, 2018

European Commission approves expanded label for Trelegy Ellipta in COPD

Nov. 9, 2018

FDA approves Bijuva for moderate to severe hot flashes due to menopause

Oct. 30, 2018

France becomes first country to market baclofen preparation to reduce alcohol consumption

Oct. 29, 2018

FDA approves Dupixent as add-on maintenance therapy for asthma

Oct. 22, 2018

FDA approves Talzenna for germline BRCA-mutated HER2-negative breast cancer

Oct. 17, 2018

FDA approves Yutiq for chronic noninfectious posterior segment uveitis

Oct. 15, 2018

Revcovi approved in U.S. for ADA-SCID

Oct. 8, 2018

FDA approves Nuzyra for CABP and ABSSSI

Oct. 3, 2018

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...